Brief: Cantargia Reports Progress Towards Start Of DOD-Sponsored Clinical Trial

Cantargia AB

27/03/2024 06:43

March 27 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA REPORTS PROGRESS TOWARDS START OF DOD-SPONSORED
CLINICAL TRIAL OF NADUNOLIMAB IN LEUKEMIA
    * CURRENT PLAN IS TO COMMENCE TRIAL DURING SUMMER OF 2024,
PENDING
REGULATORY APPROVAL
    * TRIAL IS FINANCED THROUGH A GRANT FROM US DEPARTMENT OF
DEFENSE
(DOD)

Source text for Eikon:  ID:nMFN3ZSwC0 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))